SCHEMBL7814890

SCHEMBL7814890

CNCCn1nc2c3c(c(NCCN)ccc31)C(=O)c1ccncc1-2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 1/20 0.48
MUS81 Q96NY9 1/20 0.48
TOP2A P11388 6/20 0.44
KDM4C Q9H3R0 1/20 0.34
TP53 P04637 3/20 0.32
MAPT P10636 3/20 0.32
BLM P54132 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 2/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
APP P05067 1/20 0.32
POLB P06746 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
THRB P10828 1/20 0.32
SNCA P37840 1/20 0.32
BRCA1 P38398 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817765 0.96 ECE1 (0.48) ECE1MUS81TOP2AKDM4CTP53
SCHEMBL7810430 0.94 TOP2A (0.45) ECE1MUS81TOP2AKDM4CTP53
SCHEMBL7811757 0.93 TOP2A (0.48) ECE1MUS81TOP2ATP53MAPT
SCHEMBL7804859 0.92 TOP2A (0.44) ECE1MUS81TOP2AKDM4CTP53
SCHEMBL7814297 0.92 ECE1 (0.49) ECE1MUS81TOP2AKDM4CTP53
SCHEMBL7804823 0.91 TOP2A (0.44) ECE1MUS81TOP2AKDM4CTP53
Hydrochloric Acid SCHEMBL7823890 0.91 ECE1 (0.48) ECE1MUS81TOP2AKDM4CTP53
SCHEMBL7814689 0.91 TOP2A (0.45) ECE1MUS81TOP2AKDM4CTP53
SCHEMBL7811837 0.90 ECE1 (0.48) ECE1MUS81TOP2AKDM4CTP53
SCHEMBL7809541 0.89 TOP2A (0.49) ECE1MUS81TOP2AKDM4CTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP claimed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP claimed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO claimed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO claimed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed